Siro Promethazin Vidipha treat urticaria, angioedema, allergic rhinitis (90ml)

Dosage form Syrup
Specifications Bottle x 90ml
Ingredient Promethazine
Indication Allergic rhinitis, eczema, urticaria, itching, itchy skin

Ingredient

Composition information	Content
Promethazine	112.5mg

Uses

indications

Siro Promethazin 90 ml vipada is indicated in the following cases:

Treatment of symptoms of hypersensitivity reactions such as urticaria, angioedema, allergic rhinitis, conjunctivitis and itching.

sedative in adults and children over 2 years old, reducing anxiety

Treatment of insomnia in adults (temporary).

Skill of motion sickness and treatment.

pharmacokinetics

No report.

Before taking Siro Promethazin Vidipha treat urticaria, angioedema, allergic rhinitis (90ml)

How to use

Siro Promethazin 90 ml used by oral, the amount of drug with plastic cups with dosage.

Dosage

Adults

With allergens: drinking 25 mg (20 ml of syrup) before going to bed or 12.5 mg (10 ml of syrup) before meals and before going to bed (from 5 - 10 ml of syrup, 3 times/day).

Sease rooms, cargo sickness: Take 25 mg (20 ml of syrup), take 30-60 minutes before departure. The next dose can be used every 12 hours if needed.

Sedative: Take 12.5 - 50 mg (10 - 40 ml of syrup)/dose.

Random, short -term insomnia: Take 25 mg (20 ml of syrup) at night 15 - 30 minutes before going to bed. Short -term treatment within 2 - 5 days.

Children (≤2 years):

With allergens: oral 0.1 mg (0.08 ml of syrup)/kg body weight, up to 12.5 mg (10 ml of syrup), 6 hours a day and 0.5 mg (0.4 ml of syrup)/kg body weight, up to 25 mg (20 ml of syrup) before going to bed.

In case of nausea and vomiting: only used when vomiting is prolonged or know the cause. Take 0.25 - 1 mg (0.2 - 0.8 ml of syrup)/kg body weight, 2 - 6 times/day if necessary, up to 25 mg (20 ml of syrup)/dose.

Sease rooms, cargo sickness: take 0.5 mg (0.4 ml of syrup)/kg body weight, take 30-60 minutes before departure. The next dose may be used after 12 hours if necessary, up to 25 mg (20ml syrup)/time, 2 times/day.

sedation: Take 0.5 - 1 mg (0.4 - 0.8 ml of syrup)/kg/time, every 6 hours if needed, up to 50 mg (40 ml syrup)/time.

Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.

What to do when overdose?

In adults

Often occurs in inhibition of the central nervous system and mild cardiovascular system, causing hypotension, respiratory inhibition.

convulsions, deep sleep, loss of consciousness, unexpected death. It can be seen increased reflexes, increased muscle tone, loss of air conditioning, and dance. Dry mouth, dilated pupils, flushing, symptoms in the gastrointestinal tract can also be encountered.

In children

Normal reactions of increased reflexes, abnormal movements, nightmares, and respiratory inhibitors may occur.

How to handle overdose drugs

Let the patient in a breathable place.

Causes vomiting (can use ipeca syrup, but not for people who lose consciousness, but need to prevent choking, especially children).

Take activated carbon or salt bleach (such as sodium sulfate or sulfate magnesi) or gastric lavage if the patient cannot vomit.

Epilepsy: Intravenous Diazepam 5 - 10 mg (children 0.1 - 0.2 mg/kg). Very severe cases will appear anti -cholinergic resistance symptoms in the central nervous system such as stimulating state, hallucinations: treatment with physostigmin intravenously 1 - 2 mg (children 0.02 - 0.04 mg/kg) The drug is injected slowly to determine the right dose of the drug. Can be reminded after 30-60 minutes. Prepare atropine to use in case of overdose physostigmin.

Case of severe hypotension: intravenous injection that increases plasma volume and if necessary, Noradrenalin slow intravenous infusion (the starting dose of 4-5 micrograms/kg/minute).

In case of foreign symptoms, treatment with biperidin: intramuscular or intramuscular intravenous 2 - 5 mg (children 0.04 mg/kg), this can be repeated after 30 minutes.

Need to maintain good diuretic and ventilation support for patients if needed.

What to do when you forget a dose? However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Note that it should not be used double the prescribed dose.

Side Effects

When using Promethazin 90 ml of Vidapha Sio you can experience unwanted effects (ADR).

Common, ADR> 1/100

Neurology: Sleeping, blurred vision.

Skin: rash.

Other: Concentrated mucus.

Uncommon, 1/1000

Neurological: dizziness, fatigue, tinnitus, loss of coordination, double look, insomnia, tremor, epilepsy, stimulation, hysteria.

Cardiovascular: Brushing chest drum, arrhythmia. gastrointestinal tract: dry mouth or throat, nausea, vomiting.

Rare, ADR

Neurological: disorientation, loss of movement, confusion, painful urination (more common in the elderly), nightmares, abnormal excitement, restless restlessness (common in children and the elderly). Foreign tower reaction is like a rotation, crooked neck, sticking tongue (common when using high doses).

Blood: leukopenia, thrombocytopenia, granulocytosis. Skin: Hypersensitivity to light, atopic dermatitis, jaundice.

Teeth: If using the acting field will increase the risk of tooth decay due to dry mouth.

Instructions on how to handle ADR

When experiencing side effects of the drug, it is necessary to stop using and notify the doctor or go to the nearest medical facility for timely treatment.

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

contraindicated

Siro Promethazin 90 ml Vidapha contraindicated in the following cases:

Patients using imao within the previous 2 weeks.

Complete state, patients are taking central nervous system inhibitors with large doses (such as alcohol, sedation causing sleeping barbiturat group, anesthetic, painkillers that cause sleep, calm drugs ...).

Children under 2 years old.

Patients with hypersensitivity to Promethazin or any ingredient of the drug.

History of granulocytes.

Urinary retention by prostate.

Gleloms of closed angle.

Children with signs and manifestations of Reye syndrome.

Caution when using

Patients with asthma, increased glaucoma of angle, urinary retention, prostate hypertrophy, pyloric - duodenum.

Elderly people, especially intellectual decline or brain damage.

Patients with epilepsy.

Patients with severe cardiovascular disease.

People with liver failure, marrow failure.

Diabetes.

Avoid used for children and adolescents with signs and manifestations of Reye syndrome, because it can cause symptoms that are easy to mix with the central nerve signs of this syndrome, difficulty for diagnosis.

Elderly people, especially intellectual decline or brain damage. The risk of death due to apnea if used in young children.

Patients with rare genetic diseases are not tolerant fructose should not be used.

The ingredient containing sodium bisulfit can cause serious hypersensitivity reactions and bronchospasm.

Because 1 ml of syrup contains about 0.74 g of white sugar, cautious use for diabetes.

The ability to drive and operate machinery

Because Promethazine causes drowsiness, avoid using the drug while driving or operating machinery.

Pregnancy

has not determined the safety of drugs during pregnancy. Only use when the benefits of treatment are more likely to occur for the fetus.

The period of breastfeeding

Precautions when taking the drug because the risk of unwanted effects (such as excitement or abnormal stimulation) may occur in a child. So stop breastfeeding if the mother uses Promethazine. The drug can inhibit milk secretion due to the anti -anti -cholinergic effect.

Interactive drug

The drug changes the skin test results, requires the medication for at least 72 hours before testing.

metoclopramide: Do not use in combination with Promethazine.

With central neurological inhibitors: Promethazine in communion or enhance the sedative effects of opiat, other painkillers, neurological inhibitors, antihistamines, alcohol.

With epinephrine: Epinephrin's alpha - adrenergic blocker effect may be blocked if used simultaneously.

Monoamine oxydase inhibitors (IMAO): SHOULD Use can be prolonged and enhance the central nervous inhibitor and cholinergic resistance of antihistamine drugs.

Concentrated with antihistamines is phenothiazine conductivity that may increase the risk of hypotension and extracurricular reactions.

Beta - adrenergic blockers: especially propranolol, if used simultaneously, it can cause increased plasma concentrations of each drug, so it can be lowered with hypotension, non -recovered retinal disease, arrhythmia and late dysplasia.

levodopa: When used simultaneously, anti -Parkinson effects can be inhibited due to blocking dopamine receptors in the brain.

Diagnosis of pregnancy: pregnancy diagnostic test on the basis of immune response between HCG and HCG resistance can give false or false positive results.

Glucose tolerance test: increased blood glucose may occur in patients using promethazin.

Storage

Store in a dry place, the temperature does not exceed 30 ° C, avoiding light.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.